2023 Performance Snapshot of Home Health and Hospice Leaders

2023 Performance Snapshot of Home Health and Hospice Leaders

by | Jan 3, 2024 2:13 pm | Healthcare Market Updates, Home Health & Hospice

Explore the financial performance of key players in the Home Health and Hospice (HH&H) sector during 2023. From Amedisys’ steady growth to Addus’ fluctuations, discover the ups and downs, strategic moves and investor interest that defined the industry. 2023 Quarterly Stock Performance of Publicly Traded HH&H Companies: CompanyQ1 2023Q2 2023Q3 2023Q4 2023Amedisys$73.55 $91.44 $93.40 $95.06 Encompass Health$54.10 $67.71 $67.16 $66.72 The Pennant Group$14.28 $12.28 $11.13 $13.92 Addus HomeCare$106.76 $92.70 $85.19 $92.85 Enhabit$13.91 $11.50 $11.25 $10.35 Aveanna... Read More »
Aveanna Healthcare Calls Off Maxim Home Health Merger

Aveanna Healthcare Calls Off Maxim Home Health Merger

by | Feb 3, 2020 12:11 pm | Home Health & Hospice

The Federal Trade Commission has done it again. The agency closed its investigation into the merger of Aveanna Healthcare with Maxim Healthcare’s home health division, announced in February 2019. We’re accustomed to seeing headlines every few months saying the FTC plans to tighten scrutiny of hospital mergers and acquisitions. The anti-trust division has been active in the hospital sector, the majority of announced hospital mergers more often collapse under their own, unique conditions. Just last year, Care New England ended merger talks with Lifespan and Brown University, after seeing its merger with Boston’s Partners HealthCare shot down by Rhode Island’s... Read More »